Methods and compositions for treating cancer
AssigneeNew York University
InventorKenneth Cadwell
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of NS1/2 region of murine norovirus MNV or a corresponding region from a member of the Caliciviridae family or a protein encoded by any one of those regions, for treating dysbiosis, immune system dysregulation and various disorders, as well as for enhancing mucosal integrity and stimulating IFN-induced genes.
Claims11
A method for treating a subject, wherein the subject has cancer and/or is receiving a therapy for cancer, the method comprising administering to said subject a therapeutically effective amount of the NS1/2 genomic region of murine norovirus (MNV) comprising a nucleotide sequence encoded by the DNA sequence of SEQ ID NO:
- 1 or a corresponding region from a member of the Caliciviridae family or a protein encoded by any one of those regions.
A method for enhancing the effectiveness of an anti-cancer therapy in a subject in need thereof, the method comprising administering to said subject a therapeutically effective amount of the NS1/2 genomic region of murine norovirus (MNV) comprising a nucleotide sequence encoded by the DNA sequence of SEQ ID NO:
- 1 or a corresponding region from a member of the Caliciviridae family or a protein encoded by any one of those regions.
Dependencies are inferred from the claim text.